Verified active February 2, 2026

Key Highlights

  • Phibo Group is a leader in the dental industry, specializing in implanthology, prosthesis in CAD-CAM, bone regeneration, digital solutions, and services.
  • They have a strong research vocation and a high scientific component, with a focus on making useful solutions accessible to people.
  • Their commitment to science and conscience sets them apart from other companies in the industry.
  • Phibo Group has been researching, developing, manufacturing, and selling dental solutions for over 20 years.
  • Their dedication to the health and wellbeing of people drives their evolution and growth.

About Phibo Group

Phibo Group is the leading Spanish multinational in implanthology, prosthesis in CAD-CAM, bone regeneration, digital solutions, and services. With a strong research vocation and a high scientific component, Phibo Group has been researching, developing, manufacturing, and selling dental solutions for over 20 years. Their commitment to the health and wellbeing of people drives their evolution and growth. Science is the foundation for everything at Phibo Group, and their tenacity and talent for producing high-quality products are evident in their dental solutions. They are committed to making useful solutions accessible to people, which sets them apart.

Phibo Group's mission is to create a more humane world by evolving and growing with and for people. Their commitment to science and conscience is what makes them different. They are dedicated to improving things and making a significant impact in the dental industry. Their focus on research and development ensures that their solutions are proven and valuable for their public and the sector in general.

Phibo Group's dedication to science and conscience is evident in their approach to dental solutions. They are committed to making useful solutions accessible to people, which sets them apart from other companies in the industry. Their focus on research and development ensures that their solutions are proven and valuable for their public and the sector in general. Phibo Group is a leader in the dental industry, and their commitment to science and conscience is what makes them different.

Connect with Phibo Group

Why Contact Phibo Group?

B2B professionals would contact Phibo Group for their expertise in dental solutions, commitment to research and development, and dedication to making useful solutions accessible to people. Their focus on science and conscience sets them apart in the industry.

Who Should Contact Phibo Group for Business?

Sales teams selling dental solutions, recruiters seeking roles in research and development, and partners offering digital solutions in the dental industry should reach out to Phibo Group.

Categories

  • dental solutions
  • implanthology
  • prosthesis
  • CAD-CAM
  • bone regeneration
  • digital solutions
  • research and development
  • healthcare technology
  • medical devices
  • science and conscience

Frequently Asked Questions

How many employees does Phibo Group have?
Phibo Group has approximately 189 employees.
Where is Phibo Group headquartered?
Sentmenat, Barcelona, Spain
What industry is Phibo Group in?
Phibo Group operates in Dental Solutions, Medical Devices, Healthcare Technology.
What is the email format at Phibo Group?
Phibo Group uses the email format flast@phibo.com.
Is Phibo Group still active?
Yes, Phibo Group was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to Phibo Group?
Research Phibo Group's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to Phibo Group?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from